194.14
+8.62
+(4.65%)
As of April 8 at 7:05:26 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 9 | 16 | 16 |
| Avg. Estimate | 2.63B | 2.68B | 10.3B | 11.03B |
| Low Estimate | 2.62B | 2.67B | 10.29B | 10.96B |
| High Estimate | 2.64B | 2.7B | 10.32B | 11.12B |
| Year Ago Sales | 2.47B | 2.5B | 9.6B | 10.3B |
| Sales Growth (year/est) | 6.28% | 7.19% | 7.32% | 7.14% |
EPS Trend
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0HYJ.L | -- | -- | -- | -- |
| S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/27/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 3/27/2025 |
| Maintains | UBS: Buy to Buy | 3/27/2025 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 3/27/2025 |
| Maintains | Truist Securities: Buy to Buy | 3/27/2025 |
| Maintains | Baird: Neutral to Neutral | 3/27/2025 |